Cardiomyopathies
📧 Sign up to get email alerts when something new happens for Cardiomyopathies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: Pilot Study of an NTproBNP Guided Strategy of Cardioprotection [Phase 1, Phase 2]
Pilot study results explore an NTproBNP-guided strategy to cardioprotection during chemotherapy in patients with cardiotoxicity risks.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Body Surface Area Prediction Impacts on Ventricular Dilatation Prevalence
A completed clinical trial from the University of Turin examines how body surface area prediction affects the observed prevalence of ventric…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: BIOTRONIK Conduction System Pacing With the Solia Lead [NA]
ClinicalTrials.gov update reports that the BIOTRONIK conduction system pacing trial using the Solia lead has completed and posted results. I…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: LBBAP Data Collection Registry
This update covers the completed Left Bundle Branch Area Pacing (LBBAP) Data Collection Registry sponsored by Abbott Medical Devices, with r…
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart Disease [Phase 3]
A Phase 3 trial comparing catheter ablation to amiodarone for treating premature ventricular complexes in patients with structural heart dis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Sudden Cardiac Death - Screening Of Risk Factors
This clinical trial update describes efforts to screen risk factors for Sudden cardiac death and related cardiomyopathies.
-
CLINICAL_TRIALS trial_result · 2008-01-17Clinical Trial Update: VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Feasibility Trial [Phase 2]
Phase 2 feasibility trial of the VentrAssist LVAD as a bridge to cardiac transplantation has completed.